Brian Hill, MD, PhD of Cleveland Clinic, gives an overview of the updates surrounding CLL treatments, specifically how CAR T-Cell therapy will be the best line of therapy for patients who fail novel agents at the 58th ASH Annual Meeting in San Diego, CA.
CAR T-cell Therapy May Be the Future Next Line of Attack in CLL
